Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
57 participants
INTERVENTIONAL
2010-03-31
2011-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Reducing Sedentary Behavior vs. Increasing Physical Activity in Older Adults
NCT02146001
The Association Between Sedentary Behaviour and Cardiometabolic Health in Trained Athletes
NCT04711928
Daily Goal Setting to Increase Everyday Physical Activity and Promote Cognitive Health in Midlife
NCT05826379
Sedentary Behavior, Cardiovascular Function, and Sleep
NCT04137068
The Effect of Exercise Intensity on Adherence
NCT05057416
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control group
Group had outcome measures collected and were instructed to not change activity and sedentary time behavior
No interventions assigned to this group
Exercise
Participants performed 5 days per week, 40 min per session of exercise training under direct supervision of personal trainer.
exercise training
12 weeks, 5 days of week, 40 min per session of exercise training
Sedentary time reduction
participants were give strategies to reduce sedentary time
sedentary time reduction
participants provided with strategies to decrease sitting
exercise plus sedentary time reduction
Participants completed exercise training (5 days per week, 40 min per session) plus were given sedentary time reduction intervention
exercsie training plus sedentary time reduction
12 weeks of exercise training (5 days a week, 40 min per session) plus given strategies for reducing sitting time
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
exercise training
12 weeks, 5 days of week, 40 min per session of exercise training
sedentary time reduction
participants provided with strategies to decrease sitting
exercsie training plus sedentary time reduction
12 weeks of exercise training (5 days a week, 40 min per session) plus given strategies for reducing sitting time
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. Pre-hypertensive: resting blood pressure between 125-160 mm Hg systolic and/or 85-100 mm Hg diastolic,
2. overweight/obese: body mass index (BMI) between 25 and 45 kg∙m-2,
3. high central adiposity: as defined by elevated natural waist circumference (\> 102 cm \[males\] \> 88cm \[females\]), a surrogate measure of visceral fat
4. low aerobic fitness (VO2 peak ≤ 50th percentile of age and sex specific norms)
5. exercising less than three days per week for less than 20 minutes per session for the preceding six months
Exclusion Criteria
* wheelchair use or musculoskeletal problems that affected mobility,
* life-threatening illness (e.g., terminal cancer),
* chronic diseases (e.g., diagnosed heart disease, diabetes, emphysema) or
* any condition for which a physician did not recommend exercise. Participants were excluded if they had gastric bypass or lap-band surgery within the last year, were taking medication for type II diabetes (e.g. metformin) or beta-blocker medication for high blood pressure.
20 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Heart, Lung, and Blood Institute (NHLBI)
NIH
University of Massachusetts, Amherst
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UMass Amherst Physical Activity and Health Lab
Amherst, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Kozey-Keadle
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.